Advanced Enzyme Technologies Ltd. - Research Center
540025 ADVENZYMES Group (B) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
22.37 |
22.36 |
22.35 |
22.34 |
22.33 |
Share application money
Preference share capital
Reserves & surplus
502.97 |
457.35 |
410.48 |
344.54 |
293.62 |
Secured loans
0.01 |
0.18 |
0.32 |
8.62 |
18.21 |
Unsecured loans
Total
525.34 |
480.53 |
435.76 |
379.11 |
337.68 |
Gross block
200.55 |
180.53 |
170.63 |
158.57 |
120.99 |
Less : revaluation reserve
Less : accumulated depreciation
57.69 |
48.50 |
39.60 |
31.62 |
23.64 |
Net block
142.86 |
132.03 |
131.03 |
126.95 |
97.35 |
Capital work-in-progress
11.03 |
8.68 |
7.34 |
9.96 |
7.00 |
Investments
201.47 |
189.37 |
184.48 |
120.85 |
120.46 |
Current assets, loans & advances
220.45 |
199.55 |
166.40 |
164.92 |
151.07 |
Less : current liabilities & provisions
50.46 |
49.09 |
53.49 |
43.57 |
38.21 |
Total net current assets
169.98 |
150.45 |
112.91 |
121.36 |
112.86 |
Miscellaneous expenses not written
Total
525.34 |
480.53 |
435.76 |
379.11 |
337.68 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
13.69 |
8.64 |
11.60 |
16.05 |
30.86 |
Number of equity sharesoutstanding (Lacs)
1118.24 |
1118.01 |
1117.28 |
1116.78 |
1116.49 |